BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3002 related articles for article (PubMed ID: 30661105)

  • 61. Delta-9-Tetrahydrocannabinol, Cannabidiol, and Acute Psychotomimetic States: A Balancing Act of the Principal Phyto-Cannabinoids on Human Brain and Behavior.
    Ganesh S; Cortes-Briones J; Schnakenberg Martin AM; Skosnik PD; D'Souza DC; Ranganathan M
    Cannabis Cannabinoid Res; 2023 Oct; 8(5):846-856. PubMed ID: 35319274
    [No Abstract]   [Full Text] [Related]  

  • 62. Cannabidiol potentiates Δ⁹-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats.
    Klein C; Karanges E; Spiro A; Wong A; Spencer J; Huynh T; Gunasekaran N; Karl T; Long LE; Huang XF; Liu K; Arnold JC; McGregor IS
    Psychopharmacology (Berl); 2011 Nov; 218(2):443-57. PubMed ID: 21667074
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Orally administered cannabidiol does not produce false-positive tests for Δ
    McCartney D; Kevin RC; Suraev AS; Irwin C; Grunstein RR; Hoyos CM; McGregor IS
    Drug Test Anal; 2022 Jan; 14(1):137-143. PubMed ID: 34412166
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model.
    Casey SL; Mitchell VA; Sokolaj EE; Winters BL; Vaughan CW
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955774
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Interactions between cannabidiol and Δ
    Todd SM; Zhou C; Clarke DJ; Chohan TW; Bahceci D; Arnold JC
    Eur Neuropsychopharmacol; 2017 Feb; 27(2):132-145. PubMed ID: 28043732
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cannabidiol and Delta-9-Tetrahydrocannabinol Interactions in Male and Female Rats With Persistent Inflammatory Pain.
    Britch SC; Craft RM
    J Pain; 2023 Jan; 24(1):98-111. PubMed ID: 36122809
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada.
    Hammond D; Goodman S
    Cannabis Cannabinoid Res; 2022 Jun; 7(3):345-354. PubMed ID: 33998866
    [No Abstract]   [Full Text] [Related]  

  • 68. A Double-Blind, Randomized, Controlled Crossover Trial of Cannabis in Adults with Tourette Syndrome.
    Abi-Jaoude E; Bhikram T; Parveen F; Levenbach J; Lafreniere-Roula M; Sandor P
    Cannabis Cannabinoid Res; 2023 Oct; 8(5):835-845. PubMed ID: 36040329
    [No Abstract]   [Full Text] [Related]  

  • 69. Drug-drug interactions as a result of co-administering Δ
    Rong C; Carmona NE; Lee YL; Ragguett RM; Pan Z; Rosenblat JD; Subramaniapillai M; Shekotikhina M; Almatham F; Alageel A; Mansur R; Ho RC; McIntyre RS
    Expert Opin Drug Saf; 2018 Jan; 17(1):51-54. PubMed ID: 29082802
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats.
    Parker LA; Burton P; Sorge RE; Yakiwchuk C; Mechoulam R
    Psychopharmacology (Berl); 2004 Sep; 175(3):360-6. PubMed ID: 15138755
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial.
    Grimison P; Mersiades A; Kirby A; Lintzeris N; Morton R; Haber P; Olver I; Walsh A; McGregor I; Cheung Y; Tognela A; Hahn C; Briscoe K; Aghmesheh M; Fox P; Abdi E; Clarke S; Della-Fiorentina S; Shannon J; Gedye C; Begbie S; Simes J; Stockler M
    Ann Oncol; 2020 Nov; 31(11):1553-1560. PubMed ID: 32801017
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Practical considerations in medical cannabis administration and dosing.
    MacCallum CA; Russo EB
    Eur J Intern Med; 2018 Mar; 49():12-19. PubMed ID: 29307505
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model.
    Mitchell VA; Harley J; Casey SL; Vaughan AC; Winters BL; Vaughan CW
    Neuropharmacology; 2021 May; 189():108529. PubMed ID: 33741405
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats.
    Taffe MA; Creehan KM; Vandewater SA
    Br J Pharmacol; 2015 Apr; 172(7):1783-91. PubMed ID: 25425111
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew).
    Parker LA; Kwiatkowska M; Burton P; Mechoulam R
    Psychopharmacology (Berl); 2004 Jan; 171(2):156-61. PubMed ID: 13680081
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effects of cannabidiol (CBD) on Δ⁹-tetrahydrocannabinol (THC) self-administration in male and female Long-Evans rats.
    Wakeford AGP; Wetzell BB; Pomfrey RL; Clasen MM; Taylor WW; Hempel BJ; Riley AL
    Exp Clin Psychopharmacol; 2017 Aug; 25(4):242-248. PubMed ID: 28682102
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Randomized, Triple-Blind, Comparator-Controlled Parallel Study Investigating the Pharmacokinetics of Cannabidiol and Tetrahydrocannabinol in a Novel Delivery System, Solutech, in Association with Cannabis Use History.
    Berl V; Hurd YL; Lipshutz BH; Roggen M; Mathur EJ; Evans M
    Cannabis Cannabinoid Res; 2022 Dec; 7(6):777-789. PubMed ID: 35787693
    [No Abstract]   [Full Text] [Related]  

  • 78. A randomised, placebo-controlled, double blind, crossover trial on the effect of a 20:1 cannabidiol: Δ9-tetrahydrocannabinol medical cannabis product on neurocognition, attention, and mood.
    Manning B; Hayley AC; Catchlove S; Stough C; Downey LA
    Eur Neuropsychopharmacol; 2024 May; 82():35-43. PubMed ID: 38490083
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being.
    Morgan CJ; Gardener C; Schafer G; Swan S; Demarchi C; Freeman TP; Warrington P; Rupasinghe I; Ramoutar A; Tan N; Wingham G; Lewis S; Curran HV
    Psychol Med; 2012 Feb; 42(2):391-400. PubMed ID: 21798112
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A role for cannabinoids in the treatment of myotonia? Report of compassionate use in a small cohort of patients.
    Montagnese F; Stahl K; Wenninger S; Schoser B
    J Neurol; 2020 Feb; 267(2):415-421. PubMed ID: 31655890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 151.